Evidence map›Paper›PMID 31823155›Full record

ArticleNeurogenetics2020

Neurodevelopmental phenotype associated with CHD8-SUPT16H duplication.

Thomas Smol, Caroline Thuillier, Elise Boudry-Labis, Anne Dieux-Coeslier, Bénédicte Duban-Bedu, Roseline Caumes, Sonia Bouquillon, Sylvie Manouvrier-Hanu, Catherine Roche-Lestienne, Jamal Ghoumid

Abstract read
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Highlighting the Dystonic Phenotype Related to GNAO1.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  6. Review
  7. Article
  8. Further delineation of the neurodevelopmental phenotypic spectrum associated to 14q11.2 microduplication.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  9. A Novel Chd8 Mutant Mouse Displays Altered Ultrasonic Vocalizations and Enhanced Motor Coordination.Autism research : official journal of the International Society for Autism Research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Thomas SmolEA7364 - RADEME, Université de Lille, F-59000, Lille, France.
Caroline ThuillierEA7364 - RADEME, Université de Lille, F-59000, Lille, France.
Elise Boudry-LabisEA7364 - RADEME, Université de Lille, F-59000, Lille, France.
Anne Dieux-CoeslierInstitut de Génétique Médicale, CHU Lille, F-59000, Lille, France.
Bénédicte Duban-BeduCentre de Génétique Chromosomique, GHICL, F-59000, Lille, France.
Roseline CaumesClinique de Génétique Guy Fontaine, CHU Lille, F-59000, Lille, France.
Sonia BouquillonEA7364 - RADEME, Université de Lille, F-59000, Lille, France.
Sylvie Manouvrier-HanuInstitut de Génétique Médicale, CHU Lille, F-59000, Lille, France.
Catherine Roche-LestienneEA7364 - RADEME, Université de Lille, F-59000, Lille, France.
Jamal GhoumidInstitut de Génétique Médicale, CHU Lille, F-59000, Lille, France. jamal.ghoumid@chru-lille.fr.ORCID 0000-0002-7111-0050
Université de Lille · FRCentre Hospitalier Universitaire de Lille · FRGroupe Hospitalier de l'Institut Catholique de Lille · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microdeletions encompassing 14q11.2 locus, involving SUPT16H and CHD8, were shown to cause developmental delay, intellectual disability, autism spectrum disorders and macrocephaly. Variations leading to CHD8 haploinsufficiency or loss of function were also shown to lead to a similar phenotype. Recently, a 14q11.2 microduplication syndrome, encompassing CHD8 and SUPT16H, has been described, highlighting the importance of a tight control of at least CHD8 gene-dosage for a normal development. There have been only a few reports of 14q11.2 microduplications. Patients showed variable neurodevelopmental issues of variable severity. Breakpoints of the microduplications were non-recurrent, making interpretation of the CNV and determination of their clinical relevance difficult. Here, we report on two patients with 14q11.2 microduplication encompassing CHD8 and SUPT16H, one of whom had normal intelligence. Review of previous reports describing patients with comparable microduplications allowed for a more precise delineation of the condition and widening of the phenotypic spectrum.

Indexed as

Gene DuplicationBrainCell Cycle ProteinsChildDNA-Binding ProteinsFemaleHumansMaleNeurodevelopmental DisordersPhenotypeTranscription FactorsCell Cycle ProteinsCHD8 protein, humanDNA-Binding ProteinsSUPT16H protein, humanTranscription FactorsAutism spectrum disorderBehaviour problemsCerebellar vermian anomalyCHD8-SUPT16H duplication syndrome

Identifiers

PMID31823155
OpenAlexW2993705491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.